Tradestie Institutional Equity Comparison Engine
AXNX vs MDT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MDT Overall Edge
MDT Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Medtronic plc (MDT) driven by superior Valuation, Growth & Margin, Options & Structure while AXNX counters with relative strength in Momentum & Technical. Fundamentally, AXNX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus MDT at 16.5x Forward P/E and 20.1% operating margin (+13.7% YoY). In options structure, AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MDT sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
MDT
AXNX N/M vs MDT 16.5x Fwd P/E
Growth & Margin Winner
MDT
Op Margin N/A vs 20.1% ยท YoY N/A vs +13.7%
Momentum & Technical Winner
AXNX
1Y +16.9% vs -0.4% ยท 52W Pos 50% vs 81%
Options & Structure Winner
MDT
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (15th %ile IV)
AXNX
US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap
N/A
1M Return
-26.54%
1Y Return
+16.92%
Forward P/E
N/M
Unified AI Score
52.1 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
MDT
NYSE
Medtronic plc
Electromedical & Electrotherapeutic Apparatus
$99.94
-0.67% 1D
Market Cap
$128.7B
1M Return
+3.47%
1Y Return
-0.4%
Forward P/E
16.5x
Unified AI Score
44.7 / 100
HOLD
Tech 31.0
Fund 49.0
Flow 72.0
Mom 46.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AXNX +16.92%
MDT -0.4%
Spread: +9.47 pp (AXNX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AXNX TTM Op. Margin: N/A
MDT TTM Op. Margin: 20.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXNX vs MDT. Trailing 12-month operating profitability (AXNX N/A vs MDT 20.1%) and valuation multiples (AXNX N/M vs MDT 16.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AXNX | MDT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $128.7B | Larger Scale | MDT |
| Trailing P/E Ratio Valuation | N/M | 24.7x | Lower Multiple | MDT |
| Forward P/E Ratio Valuation | N/M | 16.5x | Lower Multiple | MDT |
| Revenue Growth (YoY) Growth | N/A | +13.7% | Higher Growth | MDT |
| Operating Margin (TTM) Profitability | N/A | 20.1% | Higher Margin | MDT |
| Net Profit Margin Profitability | N/A | 13.9% | Higher Margin | MDT |
| Return on Equity (ROE) Capital Efficiency | N/A | 10.7% | Higher ROE | MDT |
| 52-Week Range Position Momentum | 50% ($0โ$1) | 81% ($73โ$106) | Stronger Trend | MDT |
| Beta / 30D Volatility Risk Regime | N/A | 0.13ฮฒ ยท 30% Vol | Lower Realized Risk | MDT |
| Unified Institutional Score Composite Signal | 52.1 / 100 (HOLD) | 44.7 / 100 (HOLD) | Higher Composite | AXNX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AXNX vs MDT Buy Guide
AXNX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
MDT
CONSOLIDATION
66d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
15th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AXNX nor MDT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.